Foldax Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective...
Read more
Axial Therapeutics announced that it is building on its clinical development science and operations capabilities through recent key appointments....
Read more
Bio-IT World has announced the entries in our first Bio-IT World Europe Best of Show Awards. Entries from Dassault...
Read more
Axial Therapeutics Inc. announced that A. Stewart Campbell, Ph.D., Chief Executive Officer, will present in two seminars at BioJapan...
Read more
FGC Plasma Solutions partners with UVA's Hypersonic Project to provide an essential piece of highly specialized equipment - plasma...
Read more
Center for Contemporary Sciences (CCS) Applauds the Senate for Passing the FDA Modernization Act 2.0
The U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...
Read more
Linnaeus Therapeutics, Inc. announced that on June 28, 2022 the U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,369,618 ('618...
Read more
Axial Therapeutics announced that A. Stewart Campbell, Ph.D., will participate in a panel entitled “The Next Wave of Targeted...
Read more
Linnaeus Therapeutics announced the presentation of clinical biomarker data from its study of LNS8801 as a monotherapy and in...
Read more
Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...
Read more